These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2259069)

  • 1. The renin-angiotensin system and renal function in kidney transplantation.
    Mimran A; Mourad G; Ribstein J
    Kidney Int Suppl; 1990 Nov; 30():S114-7. PubMed ID: 2259069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension in renal transplant recipients].
    Basić-Jukić N; Jurić I; Kes P; Bubić-Filipi L; Brunetta B; Pasini J
    Acta Med Croatica; 2007 Apr; 61(2):171-6. PubMed ID: 17585473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of inhibition of angiotensin converting enzyme on hypertension following kidney transplantation].
    Ribstein J; Mourad G; Argiles A; Mion C; Mimran A
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):929-32. PubMed ID: 3099712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension in kidney transplant recipients.
    Ponticelli C; Cucchiari D; Graziani G
    Transpl Int; 2011 Jun; 24(6):523-33. PubMed ID: 21382101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors after renal transplantation.
    Bravo P; Felgueiras J; Santos C; Oliveira C; Ponce P
    Transplant Proc; 2008 Apr; 40(3):740-2. PubMed ID: 18455003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitors and renal function.
    Mimran A; Ribstein J
    J Hypertens Suppl; 1989 Sep; 7(5):S3-9. PubMed ID: 2681604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiotensin-converting enzyme for diagnosis of renal-artery stenosis.
    Re R; Novelline R; Escourrou MT; Athanasoulis C; Burton J; Haber E
    N Engl J Med; 1978 Mar; 298(11):582-6. PubMed ID: 203850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of cyclosporine on renal function in organ transplant recipients.
    Bantle JP; Paller MS; Boudreau RJ; Olivari MT; Ferris TF
    J Lab Clin Med; 1990 Feb; 115(2):233-40. PubMed ID: 2405085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between blood pressure and renin, angiotensin II and atrial natriuretic factor after renal transplantation.
    Hestin D; Mertes PM; Hubert J; Claudon M; Mejat E; Renoult E; Pertek JP; Frimat L; Burlet C; Kessler M
    Clin Nephrol; 1997 Aug; 48(2):98-103. PubMed ID: 9285146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
    Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
    Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrarenal renin-angiotensin system in renal physiology and pathophysiology.
    Johnston CI; Fabris B; Jandeleit K
    Kidney Int Suppl; 1993 Jul; 42():S59-63. PubMed ID: 8361131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocytosis after renal transplantation: risk factors and relationship with GFR.
    Nankivell BJ; Allen RD; O'Connell PJ; Chapman JR
    Clin Transplant; 1995 Oct; 9(5):375-82. PubMed ID: 8541630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and hemodynamic effects of renin-angiotensin system blockade in cardiac transplant recipients.
    Karabsheh S; Verma DR; Jain M; Stoddard G; Brunisholz K; Stehlik J; Kfoury A; Gilbert E; Bader F
    Am J Cardiol; 2011 Dec; 108(12):1836-9. PubMed ID: 22133132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does antihypertensive therapy modify chronic allograft failure?
    Raine AE
    Kidney Int Suppl; 1995 Dec; 52():S107-11. PubMed ID: 8587270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors determining the prevalence of hypertension after renal transplantation.
    Huysmans FT; Hoitsma AJ; Koene RA
    Nephrol Dial Transplant; 1987; 2(1):34-8. PubMed ID: 3110695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of acute angiotensin converting enzyme inhibitors and calcium antagonists in transplant renal artery stenosis.
    Mourad G; Ribstein J; Argiles A; Mimran A; Mion C
    Nephrol Dial Transplant; 1989; 4(1):66-70. PubMed ID: 2494601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.